Stem Cells and Tissue Repair
On this page
Direct answer
Whether an injured organ regenerates or scars is decided by its stem-cell economy. Labile tissues — marrow, gut epithelium, skin — cycle continuously and repair perfectly. Stable tissues — liver, endothelium, renal tubular epithelium — are quiescent but re-enter the cycle after injury and regenerate. Permanent tissues — cardiac myocytes, most neurons — have no meaningful regenerative pool, so healing is fibrous repair. Stem cells are defined by self-renewal and potency, running from totipotent (zygote to the eight-cell stage) through pluripotent (embryonic stem cells and induced pluripotent stem cells) to multipotent adult stem cells — haematopoietic (CD34-positive) and mesenchymal. Yamanaka's reprogramming of adult fibroblasts with OCT4, SOX2, KLF4 and c-MYC earned the 2012 Nobel Prize and made patient-specific pluripotent cells a laboratory routine.
What you must remember
- Potency ladder with examples: totipotent (zygote, blastomeres up to about the eight-cell stage — embryo plus placenta); pluripotent (inner cell mass, embryonic stem cells, iPSCs — all three germ layers, teratoma-forming); multipotent (haematopoietic, mesenchymal, neural stem cells); unipotent progenitors (spermatogonia).
- Tissue classification — the guaranteed one mark: labile (marrow, gut crypt, skin, hair follicle), stable (liver, renal tubule, endothelium, fibroblast — G0 but recruitable), permanent (myocardium, neurons, lens).
- Adult niches worth naming: haematopoietic stem cells nest in the marrow perivascular niche (CXCL12-abundant reticular cells, endothelium); intestinal stem cells are the crypt base columnar cells marked by Lgr5; corneal limbus; hair follicle bulge; satellite cells beneath skeletal muscle basement membrane.
- Clinical stem-cell medicine that exists today: allogeneic haematopoietic stem-cell transplantation for leukaemia, aplastic anaemia and thalassaemia; limbal stem-cell transplantation for chemical corneal burns — with the simple limbal epithelial transplantation (SLET) technique developed at LVPEI, Hyderabad, an Indian contribution worth quoting; cultured keratinocyte grafts in burns.
- iPSC applications: disease modelling and drug testing in the patient's own cells; the teratoma risk and genomic instability are the barriers to direct therapy — answer with that hedge.
- Cancer stem cells: tumour-maintaining subpopulations defined functionally by transplantation (CD34-positive CD38-negative in acute myeloid leukaemia is the classical phenotype); they resist chemotherapy by quiescence and drug-efflux, the biological reason for relapse.
- Repair versus regeneration: regeneration restores original architecture; fibrous repair (granulation tissue, myofibroblast contraction, collagen remodelling) restores continuity but not function — chronic injury tilts the balance toward fibrosis, and cirrhosis is the standing example.
Why the liver regenerates and the heart scars
Two patients, two organs, two outcomes. A living donor gives 60 per cent of his liver; within weeks the mass is restored, because hepatocytes are stable cells that re-enter the cycle en masse — primed by TNF-alpha and IL-6, driven by HGF and TGF-alpha, with the architecture rebuilt around the regenerating plates. Note the subtlety worth a viva mark: the liver regenerates mass, and after partial hepatectomy it does so by hepatocyte hyperplasia without stem-cell recruitment; true oval-cell-mediated regeneration appears only when hepatocytes themselves are crippled, as in fulminant hepatitis. A patient loses the same fraction of myocardium to infarction; cardiac myocytes are terminal, a small fraction may renew from progenitors over a lifetime, but clinically the necrotic muscle is replaced by granulation tissue and then a collagen scar, which holds the ventricle together at the price of compliance and contractility. The kidney tubule regenerates after ischaemic injury (acute tubular injury can fully recover if the basement membrane survives); the neuron does not. One classification, three organs, three prognoses — this reasoning is what the professional examination rewards.
Where students slip
Pluripotency is defined functionally by teratoma formation — all three germ layers in a mass — so a culture that cannot form a teratoma is not pluripotent, however it looks. Students confuse haematopoietic stem cells (CD34) with mesenchymal stromal cells (adherent, CD73, CD90, CD105) — different cells, different promises, and most current "stem-cell therapy" outside transplant uses the mesenchymal stromal label with modest evidence. And remember that regeneration needs an intact scaffold: tubular necrosis on a preserved basement membrane recovers; destruction of the scaffold, as in crush injury or cirrhosis, commits the organ to fibrosis no matter how many stem cells arrive.
Frequently asked questions
What defines a stem cell?
Self-renewal plus the capacity to differentiate into one or more mature cell types — the two properties that distinguish it from a progenitor.
Which tissues are classified as permanent?
Cardiac muscle, neurons and lens fibres — terminally differentiated cells with negligible regenerative capacity that heal by scarring.
What are Yamanaka's factors?
OCT4, SOX2, KLF4 and c-MYC — the transcription factors that reprogram somatic fibroblasts into induced pluripotent stem cells.
Why do tumours relapse after chemotherapy?
Cancer stem cells survive as quiescent, drug-effluxing tumour-maintaining populations — the AML CD34-positive CD38-negative phenotype being the classical example.
What is SLET?
Simple limbal epithelial transplantation — an Indian-developed technique of transplanting limbal stem cells on amniotic membrane to restore the corneal surface after chemical burns.